FDA Approved: LYBALVI — Original Application (Alkermes, Inc.)

View source ↗

Summary

FDA approved LYBALVI (olanzapine and samidorphan L-malate) from Alkermes as an original drug application. It is indicated for the treatment of schizophrenia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• LYBALVI (olanzapine and samidorphan L-malate)

Snippet

ORIG AP for LYBALVI (OLANZAPINE AND SAMIDORPHAN L-MALATE)